Cover Image

Hexonic derivatives as human GABA-AT inhibitors: A molecular docking approach

Human ?-aminobutyric acid aminotransferase (GABA-AT), a pyridoxal phosphate dependent enzyme is responsible for the degradation of the inhibitory neurotransmitter GABA. Currently, GABA-AT is a potential drug target for epilepsy due to the selective inhibition in brain. In this computational study, w...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dharmaraj Senthilkumar (Author), Krishnan Anbarasu (Author), Sivaraman Jayanthi (Author)
Format:	Book
Published:	Bangladesh Pharmacological Society, 2015-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evolutionary analysis of galectins and identification of potential galectin-1 inhibitors: A computational approach
by: Vipperla Bhavaniprasad, et al.
Published: (2014)

Evolutionary analysis of galectins and identification of potential galectin-1 inhibitors: A computational approach
by: Vipperla Bhavaniprasad, et al.
Published: (2014)

Integrative Approach for Designing Novel Triazole Derivatives as α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Investigations
by: Oussama Abchir, et al.
Published: (2024)

Interplay between microbial‐derived GABA and host GABA receptor signaling collectively influence the tumorigenic function of GABA in colon cancer
by: Jonathan M. Keane, et al.
Published: (2024)

Design, synthesis, molecular docking, and molecular dynamic studies of novel quinazoline derivatives as phosphodiesterase 7 inhibitors
by: Afaf A. El-Malah, et al.
Published: (2024)

Integrative computational approaches for designing novel alpha-glucosidase inhibitors based on curculigoside A derivatives: Virtual screening, molecular docking, and molecular dynamics
by: Aiyi Asnawi, et al.
Published: (2024)

Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection.
by: Anitra L Farrow, et al.
Published: (2014)

Molecular docking analysis of curcumin analogues as human neutrophil elastase inhibitors
by: Radhakrishnan Narayanaswamy, et al.
Published: (2014)

Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors
by: Zeynep Soyer, et al.
Published: (2017)

Design, synthesis and molecular docking of novel diarylcyclohexenone and diarylindazole derivatives as tubulin polymerization inhibitors
by: Riham I. Ahmed, et al.
Published: (2017)

3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors
by: Yuwei Wang, et al.
Published: (2021)

Synthesis, anti-inflammatory, molecular docking and ADME studies of new derivatives of ketoprofen as cyclooxygenases inhibitor
by: Mustafa M. Allawi, et al.
Published: (2019)

Synthesis of Novel Bis-Coumarin Derivatives as Potential Acetylcholinesterase Inhibitors: An In Vitro, Molecular Docking, and Molecular Dynamics Simulations Study
by: Zhila Zare-Akbari, et al.
Published: (2022)

STUDY OF PHENIBUT ANTIEDEMIC ACTION AND NEW GABA DERIVATIVES
by: T. N. Scherbakova, et al.
Published: (2015)

Synthesis and docking study on thiadiazolo[3,2-a][1,3]diazepin-8(5H)-one derivatives as selective GABA(A) agonists
by: Mohammad javad Taghizadeh, et al.
Published: (2016)

QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitors
by: Mourad Aloui, et al.
Published: (2024)

Design and Molecular Docking Studies of Quinazoline Derivatives as Antiproliferation
by: Anita Puspa Widiyana, et al.
Published: (2018)

Molecular docking of taraxerol acetate as a new COX inhibitor
by: Ubaid Ur Rehman, et al.
Published: (2013)

Molecular docking study of new sorafenib analogues as platelet-derived growth factor receptor inhibitors for the treatment of cancer
by: Marwan I Jihad, et al.
Published: (2023)

Plant-derived antiviral drugs as novel hepatitis B virus inhibitors: Cell culture and molecular docking study
by: Mohammad K. Parvez, et al.
Published: (2019)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020)

Exploring Novel Pyridine Carboxamide Derivatives as Urease Inhibitors: Synthesis, Molecular Docking, Kinetic Studies and ADME Profile
by: Ayesha Naseer, et al.
Published: (2022)

MOLECULAR DESIGN OF N-ACYL DERIVATIVES OF 2-(2-OXOPYROLIDIN-1-YL)-ACETAMIDE WITH GABA-ERGIC AND GLUTAMATERGIC ACTIVITIES
by: I. P. Kodonidi, et al.
Published: (2021)

Epigenetic regulation of GABA catabolism in iPSC-derived neurons: The molecular links between FGF21 and histone methylation
by: Ming-Fen Ho, et al.
Published: (2023)

Potential of plant alkaloids as dengue ns3 protease inhibitors: Molecular docking and simulation approach
by: Muhammad Tahir ul Qamar, et al.
Published: (2014)

Potential of plant alkaloids as dengue NS3 protease inhibitors: Molecular docking and simulation approach
by: Muhammad Tahir ul Qamar, et al.
Published: (2014)

Cross Docking Study Directed Toward Virtual Screening and Molecular Docking Study of Phenanthrene 1,2,4-triazine Derivatives As Novel Bcl-2 Inhibitors
by: Mohammad Hasan Jamei, et al.
Published: (2016)

Cross Docking Study Directed Toward Virtual Screening and Molecular Docking Study of Phenanthrene 1,2,4-triazine Derivatives As Novel Bcl-2 Inhibitors
by: Mohammad Hasan Jamei, et al.
Published: (2016)

Molecular Docking studies on possible Neuraminidase Inhibitors of Influenza Virus
by: Jawaria Khan, et al.
Published: (2017)

Biologically Potent Benzimidazole-Based-Substituted Benzaldehyde Derivatives as Potent Inhibitors for Alzheimer's Disease along with Molecular Docking Study
by: Bushra Adalat, et al.
Published: (2023)

Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors
by: Begüm Nurpelin Sağlık, et al.
Published: (2020)

Thiourea Derivatives as Estrogen Receptor Alpha Inhibitors for Breast Cancer Therapy: An In Silico Evaluation with ADMET Prediction and Molecular Docking
by: Hestining Puspaweni, et al.
Published: (2024)

Neuroprotective properties of GABA and its derivatives in diabetic encephalopathy in old animals
by: I. N. Tyurenkov, et al.
Published: (2023)

Modified coptisine derivatives as an inhibitor against pathogenic Rhizomucor miehei, Mycolicibacterium smegmatis (Black Fungus), Monkeypox, and Marburg virus by molecular docking and molecular dynamics simulation-based drug design approach
by: Shopnil Akash, et al.
Published: (2023)

Biological evaluation, molecular docking and DFT calculations of pyrrole-based derivatives as dual acting AChE/MAO-B inhibitors
by: Emilio Mateev, et al.
Published: (2023)

Synthesis, biological evaluation and molecular docking investigation of new sulphonamide derivatives bearing naphthalene moiety as potent tubulin polymerisation inhibitors
by: Guangcheng Wang, et al.
Published: (2021)

Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents
by: Heba M. Hesham, et al.
Published: (2018)

Binding mode of triazole derivatives as aromatase inhibitors based on docking, protein ligand interaction fingerprinting, and molecular dynamics simulation studies
by: Ayyub Mojaddami, et al.
Published: (2017)

Molecular Docking Investigation, Pharmacokinetic Analysis, and Molecular Dynamic Simulation of Some Benzoxaborole-Benzimidazole Hybrids: An Approach to Identifying Superior Onchocerca Inhibitors
by: Fabian Audu Ugbe, et al.
Published: (2023)

Molecular docking studies of some flavone analogues as α-Glucosidase inhibitors
by: Morteza Sadeghi, et al.
Published: (2020)